Neuroblastoma
Conditions
Interventions
None listed
Sponsors
Japan Children's Cancer Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with histologically diagnosed neuroblastoma by biopsy (including bone marrow sampling) of a primary or metastatic tumor and who meet the following risk categories. However, patients with localized disease who have had a total tumor resection prior to chemotherapy are not eligible.
Exclusion criteria
Exclusion criteria: 1) Cases of multiple cancers 2) Pregnant women, women who may be pregnant, or women who are breast-feeding 3) Patients with psychosis or psychiatric symptoms that make it difficult for them to participate in the study 4) Cases with other illnesses, severe complications or severe malformations for which are inappropriate to participate in the study 5) Patients with INRG stage MS younger than 18 months of age who are classified as intermediate risk by COG risk classification and subsequently determined to have an abnormal 11q
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24-month progression-free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Survival Surgical complication complications resulting from the absence of surgical treatment(e.g., tumor compression symptoms) For dumbbell tumors, concomitant symptoms at time point 2 of evaluation Subgroup analysis for progression-free survival rate and overall survival rate (e.g., INRG risk classification, COG risk classification) | — |
Countries
Japan
Contacts
Public ContactShigeki Yagyu
Kyoto Prefectural University of Medicine Department of Pediatrics
Outcome results
None listed